The AI Product Going Viral With Doctors: OpenEvidence, with CEO Daniel Nadler

OpenEvidence functions as an AI copilot for physicians, designed to navigate the overwhelming volume of medical literature by providing evidence-based, point-of-care decision support. By treating doctors as consumers rather than enterprise targets, the platform bypasses traditional, slow-moving hospital procurement processes, achieving rapid adoption through word-of-mouth. The system relies on an ensemble of specialized models trained exclusively on peer-reviewed literature—including a strategic partnership with the New England Journal of Medicine—to eliminate the risks of public-internet hallucinations. This architecture allows clinicians to address complex, rare patient "edge cases" with high-fidelity, verifiable data. By democratizing access to subspecialty-level knowledge, the platform bridges the gap between rapidly doubling medical research and clinical application, ultimately enhancing patient outcomes across diverse settings, from elite research hospitals to rural community practices.